These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 21503829)
1. Usefulness of (13)N-NH (3) PET in the evaluation of brain lesions that are hypometabolic on (18)F-FDG PET. Xiangsong Z; Weian C; Dianchao Y; Xiaoyan W; Zhifeng C; Xiongchong S J Neurooncol; 2011 Oct; 105(1):103-7. PubMed ID: 21503829 [TBL] [Abstract][Full Text] [Related]
2. Differentiation of recurrent astrocytoma from radiation necrosis: a pilot study with 13N-NH3 PET. Xiangsong Z; Weian C J Neurooncol; 2007 May; 82(3):305-11. PubMed ID: 17120157 [TBL] [Abstract][Full Text] [Related]
3. Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET. Chung JK; Kim YK; Kim SK; Lee YJ; Paek S; Yeo JS; Jeong JM; Lee DS; Jung HW; Lee MC Eur J Nucl Med Mol Imaging; 2002 Feb; 29(2):176-82. PubMed ID: 11926379 [TBL] [Abstract][Full Text] [Related]
4. Determination of brain tumor recurrence using Yamaguchi S; Hirata K; Okamoto M; Shimosegawa E; Hatazawa J; Hirayama R; Kagawa N; Kishima H; Oriuchi N; Fujii M; Kobayashi K; Kobayashi H; Terasaka S; Nishijima KI; Kuge Y; Ito YM; Nishihara H; Tamaki N; Shiga T Cancer Sci; 2021 Oct; 112(10):4246-4256. PubMed ID: 34061417 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy. Bader JB; Samnick S; Moringlane JR; Feiden W; Schaefer A; Kremp S; Kirsch CM Eur J Nucl Med; 1999 Feb; 26(2):144-51. PubMed ID: 9933348 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of He Q; Zhang L; Zhang B; Shi X; Yi C; Zhang X BMC Cancer; 2019 Apr; 19(1):332. PubMed ID: 30961564 [TBL] [Abstract][Full Text] [Related]
7. The combination of 13N-ammonia and 18F-FDG PET/CT in the identification of metabolic phenotype of primary human brain tumors. Yi C; Shi X; Yu D; Luo G; Zhang B; He Q; Zhang X Nuklearmedizin; 2019 Jun; 58(3):272-278. PubMed ID: 30995685 [TBL] [Abstract][Full Text] [Related]
8. PET Imaging of cerebral astrocytoma with 13N-ammonia. Xiangsong Z; Changhong L; Weian C; Dong Z J Neurooncol; 2006 Jun; 78(2):145-51. PubMed ID: 16739028 [TBL] [Abstract][Full Text] [Related]
9. Identify glioma recurrence and treatment effects with triple-tracer PET/CT. Li C; Yi C; Chen Y; Xi S; Guo C; Yang Q; Wang J; Sai K; Zhang J; Ke C; Chen F; Lv Y; Zhang X; Chen Z BMC Med Imaging; 2021 May; 21(1):92. PubMed ID: 34059015 [TBL] [Abstract][Full Text] [Related]
10. Comparison of F-18 FDG and C-11 methionine PET/CT for the evaluation of recurrent primary brain tumors. Tripathi M; Sharma R; Varshney R; Jaimini A; Jain J; Souza MM; Bal J; Pandey S; Kumar N; Mishra AK; Mondal A Clin Nucl Med; 2012 Feb; 37(2):158-63. PubMed ID: 22228339 [TBL] [Abstract][Full Text] [Related]
11. 13N-NH3 versus F-18 FDG in detection of intracranial meningioma: initial report. Xiangsong Z; Xingchong S; Chang Y; Xiaoyan W; Zhifeng C Clin Nucl Med; 2011 Nov; 36(11):1003-6. PubMed ID: 21975388 [TBL] [Abstract][Full Text] [Related]
12. One-day protocol for Chang Y; Donglan Y; Xinchong S; Ganhua L; Bing Z; Yao L; Rutong Z; Qiao H; Xiangsong Z Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(2):68-74. PubMed ID: 32005511 [TBL] [Abstract][Full Text] [Related]
13. Comparison of (18)F-FET and (18)F-FDG PET in brain tumors. Pauleit D; Stoffels G; Bachofner A; Floeth FW; Sabel M; Herzog H; Tellmann L; Jansen P; Reifenberger G; Hamacher K; Coenen HH; Langen KJ Nucl Med Biol; 2009 Oct; 36(7):779-87. PubMed ID: 19720290 [TBL] [Abstract][Full Text] [Related]
14. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas. Li DL; Xu YK; Wang QS; Wu HB; Li HS Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472 [TBL] [Abstract][Full Text] [Related]
16. Prediction of pathology and survival by FDG PET in gliomas. Padma MV; Said S; Jacobs M; Hwang DR; Dunigan K; Satter M; Christian B; Ruppert J; Bernstein T; Kraus G; Mantil JC J Neurooncol; 2003 Sep; 64(3):227-37. PubMed ID: 14558598 [TBL] [Abstract][Full Text] [Related]
17. [Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging]. Cai L; Gao S; Li DC; Li YS; Chen QS; Xing XL Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):134-8. PubMed ID: 19538892 [TBL] [Abstract][Full Text] [Related]
18. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. Chen W; Silverman DH; Delaloye S; Czernin J; Kamdar N; Pope W; Satyamurthy N; Schiepers C; Cloughesy T J Nucl Med; 2006 Jun; 47(6):904-11. PubMed ID: 16741298 [TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography of sodium glucose cotransport activity in high grade astrocytomas. Kepe V; Scafoglio C; Liu J; Yong WH; Bergsneider M; Huang SC; Barrio JR; Wright EM J Neurooncol; 2018 Jul; 138(3):557-569. PubMed ID: 29525972 [TBL] [Abstract][Full Text] [Related]
20. The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas. Gross MW; Weber WA; Feldmann HJ; Bartenstein P; Schwaiger M; Molls M Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):989-95. PubMed ID: 9719107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]